CRISPR Therapeutics AG
CRSP
$54.13
-$0.19-0.35%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -14.01% | -11.99% | 12.41% | 11.26% | 13.21% |
| Total Receivables | -- | -- | -86.88% | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.60% | -23.25% | -21.30% | -60.28% | -59.07% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -13.77% | -11.89% | 1.52% | 10.41% | 8.11% |
|
|
|||||
| Total Current Assets | -13.77% | -11.89% | 1.52% | 10.41% | 8.11% |
| Net Property, Plant & Equipment | -9.95% | -9.65% | -9.28% | -8.81% | -8.46% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -59.20% | 37.85% | 101.59% | 97.53% | 90.79% |
| Total Assets | -13.25% | -11.19% | 0.56% | 8.11% | 6.50% |
|
|
|||||
| Total Accounts Payable | 3.18% | -20.65% | -61.44% | -40.43% | -65.74% |
| Total Accrued Expenses | -29.91% | -72.72% | -3.10% | -7.88% | -3.31% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 9.58% | 9.47% | 10.64% | 12.55% | 10.91% |
| Total Finance Division Other Current Liabilities | -21.73% | -12.66% | 14.12% | -30.78% | 25.67% |
| Total Other Current Liabilities | -21.73% | -12.66% | 14.12% | -30.78% | 25.67% |
| Total Current Liabilities | -18.35% | 0.38% | -19.31% | -19.26% | -3.77% |
|
|
|||||
| Total Current Liabilities | -18.35% | 0.38% | -19.31% | -19.26% | -3.77% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -8.11% | -7.80% | -7.44% | -7.03% | -6.72% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.51% | -8.82% | 5.32% | -24.59% | -8.86% |
| Total Liabilities | -11.23% | -5.11% | -10.62% | -11.86% | -5.80% |
|
|
|||||
| Common Stock & APIC | 5.92% | 3.91% | 14.43% | 15.37% | 15.16% |
| Retained Earnings | -37.64% | -34.55% | -36.64% | -22.00% | -27.21% |
| Treasury Stock & Other | 235.29% | 352.35% | -3.94% | 253.10% | 67.22% |
| Total Common Equity | -13.62% | -12.23% | 2.62% | 12.26% | 9.08% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -13.62% | -12.23% | 2.62% | 12.26% | 9.08% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -13.62% | -12.23% | 2.62% | 12.26% | 9.08% |
|
|
|||||